On March 11, 2022, Douglas A. Roeder, notified Tandem Diabetes Care, Inc. of his decision not to stand for re-election at the Company's 2022 Annual Meeting of Stockholders (the 2022 Annual Meeting). Mr. Roeder has served on the Board since May 2009 and is currently serving as a Class III director with a term that will end concurrent with the 2022 Annual Meeting. The decision by Mr. Roeder not to stand for re-election did not involve a disagreement with the Company on any matter relating to the Company's operations, policies or practices.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
45.33 USD | -0.26% | -7.21% | +53.25% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+53.25% | 2.93B | |
-5.81% | 180B | |
-1.63% | 106B | |
-4.14% | 67.55B | |
-6.56% | 46.11B | |
+13.22% | 45.79B | |
+6.13% | 41.61B | |
+19.93% | 31.07B | |
+13.61% | 24.77B | |
-5.36% | 24.27B |
- Stock Market
- Equities
- TNDM Stock
- News Tandem Diabetes Care, Inc.
- Tandem Diabetes Care, Inc. Announces That Douglas A. Roeder Notified His Decision Not to Stand for Re-Election